Other Species / Isoforms
  PARN (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K9-ub
EIIRSNFkSNLHKVY
0 1
PARN (human) EIIRSNFkSNLHKVY K9-ub
PARN (mouse) EIIRSNFKINLHKVY K9
PARN (rat) EIIRSNFKINLPKVY K9
S61-p
YQKLKKHsMDFLLFQ
0 1
PARN (human) YQKLKKHsMDFLLFQ S61-p
PARN (mouse) YQKLKKHSMDFLLFQ S61
PARN (rat) YQKLKKHSMDFLLFQ S61
K82-ub
KYDYTDSkYITKSFN
0 1
PARN (human) KYDYTDSkYITKSFN K82-ub
PARN (mouse) KYDHTDSKHVTKSFN K82
PARN (rat) KYDHANSKHVTKSFN K82
S151-p
EQYDEKRsQANGAGA
0 1
PARN (human) EQYDEKRsQANGAGA S151-p
PARN (mouse) EQFDEKRSQANGAGA S151
PARN (rat) EQFDEKRSQANGAGA S151
Y161-p
NGAGALSyVsPNtsk
0 2
PARN (human) NGAGALSyVsPNtsk Y161-p
PARN (mouse) gap -
PARN (rat) gap -
S163-p
AGALSyVsPNtskCP
0 33
PARN (human) AGALSyVsPNtskCP S163-p
PARN (mouse) gap -
PARN (rat) gap -
T166-p
LSyVsPNtskCPVtI
0 1
PARN (human) LSyVsPNtskCPVtI T166-p
PARN (mouse) gap -
PARN (rat) gap -
S167-p
SyVsPNtskCPVtIP
0 2
PARN (human) SyVsPNtskCPVtIP S167-p
PARN (mouse) ANGAGALAKCPVTIP A160
PARN (rat) ANGAGALTKCPVTIP T160
K168-ub
yVsPNtskCPVtIPE
0 1
PARN (human) yVsPNtskCPVtIPE K168-ub
PARN (mouse) NGAGALAKCPVTIPE K161
PARN (rat) NGAGALTKCPVTIPE K161
T172-p
NtskCPVtIPEDQKk
0 1
PARN (human) NtskCPVtIPEDQKk T172-p
PARN (mouse) ALAKCPVTIPEDQKK T165
PARN (rat) ALTKCPVTIPEDQKK T165
K179-ub
tIPEDQKkFIDQVVE
0 1
PARN (human) tIPEDQKkFIDQVVE K179-ub
PARN (mouse) TIPEDQKKFIDQVIE K172
PARN (rat) TIPEDQKKFIDQVIE K172
K198-ub
LLQSEENkNLDLEPC
0 1
PARN (human) LLQSEENkNLDLEPC K198-ub
PARN (mouse) FLQSEEKRSLELDPC R191
PARN (rat) under review -
K220-ac
IYQTLSWkYPkGIHV
0 3
PARN (human) IYQTLSWkYPkGIHV K220-ac
PARN (mouse) IYQTLSWKYPKGIHV K213
PARN (rat) IYQTLSWKYPKGIHV K213
K223-ub
TLSWkYPkGIHVETL
0 1
PARN (human) TLSWkYPkGIHVETL K223-ub
PARN (mouse) TLSWKYPKGIHVETL K216
PARN (rat) TLSWKYPKGIHVETL K216
Y238-p
ETEKKERyIVIskVD
0 1
PARN (human) ETEKKERyIVIskVD Y238-p
PARN (mouse) ETDKKERHIVISKVD H231
PARN (rat) ETDKKERHIVISKVD H231
S242-p
KERyIVIskVDEEER
0 1
PARN (human) KERyIVIskVDEEER S242-p
PARN (mouse) KERHIVISKVDEEER S235
PARN (rat) KERHIVISKVDEEER S235
K243-ac
ERyIVIskVDEEERk
0 1
PARN (human) ERyIVIskVDEEERk K243-ac
PARN (mouse) ERHIVISKVDEEERK K236
PARN (rat) ERHIVISKVDEEERK K236
K250-ac
kVDEEERkRREQQKH
0 1
PARN (human) kVDEEERkRREQQKH K250-ac
PARN (mouse) KVDEEERKRREQEKY K243
PARN (rat) KVDEEERKRREQEKY K243
K259-ub
REQQKHAkEQEELND
0 2
PARN (human) REQQKHAkEQEELND K259-ub
PARN (mouse) REQEKYTKEQEELND K252
PARN (rat) REQEKYAKEQEELND K252
K326-ub
FPRLLDTkLMAsTQP
0 5
PARN (human) FPRLLDTkLMAsTQP K326-ub
PARN (mouse) FPRLLDTKLMASTQP K319
PARN (rat) FPRLLDTKLMASTQP K319
S330-p
LDTkLMAsTQPFKDI
0 1
PARN (human) LDTkLMAsTQPFKDI S330-p
PARN (mouse) LDTKLMASTQPFKDI S323
PARN (rat) LDTKLMASTQPFKDI S323
T341-p
FKDIINNtsLAELEk
0 2
PARN (human) FKDIINNtsLAELEk T341-p
PARN (mouse) FKDIINNTSLAELEK T334
PARN (rat) FKDIINNTSLAELEK T334
S342-p
KDIINNtsLAELEkR
0 1
PARN (human) KDIINNtsLAELEkR S342-p
PARN (mouse) KDIINNTSLAELEKR S335
PARN (rat) KDIINNTSLAELEKR S335
K348-ub
tsLAELEkRLKETPF
0 1
PARN (human) tsLAELEkRLKETPF K348-ub
PARN (mouse) TSLAELEKRLKETPF K341
PARN (rat) TSLAELEKRLKETPF K341
S409-p
SPPKIHVsARSkLIE
0 1
PARN (human) SPPKIHVsARSkLIE S409-p
PARN (mouse) SPPKMCVSARSKLIE S402
PARN (rat) SPPKTCVSARSKLIE S402
K413-ub
IHVsARSkLIEPFFN
0 3
PARN (human) IHVsARSkLIEPFFN K413-ub
PARN (mouse) MCVSARSKLIEPFFN K406
PARN (rat) TCVSARSKLIEPFFN K406
K421-ub
LIEPFFNkLFLMRVM
0 1
PARN (human) LIEPFFNkLFLMRVM K421-ub
PARN (mouse) LIEPFFNKLFLMRVM K414
PARN (rat) LIEPFFNKLFLMRVM K414
T451-p
RDHVLHVtFPKEWKT
0 1
PARN (human) RDHVLHVtFPKEWKT T451-p
PARN (mouse) RDHVLHVTFPKEWKT T444
PARN (rat) RDHVLHVTFPKEWKT T444
K499-ac
KIAVNTSkYAESYRI
Upstream
0 3
Treatment
  • MS275
  • vorinostat
PARN (human) KIAVNTSkYAESYRI K499-ac
PARN (mouse) QIAVNTSKYAESYRI K492
PARN (rat) QIAVNTSKYAESYRI K492
K499-ub
KIAVNTSkYAESYRI
0 1
PARN (human) KIAVNTSkYAESYRI K499-ub
PARN (mouse) QIAVNTSKYAESYRI K492
PARN (rat) QIAVNTSKYAESYRI K492
K520
MGRKQEEKQIKRKWT
0 1
PARN (human) MGRKQEEKQIKRKWT K520
PARN (mouse) VGKKQEGkQVkRKWT K513-ac
PARN (rat) VGKKQESKQVKRKWT K513
K523
KQEEKQIKRKWTEDs
0 2
PARN (human) KQEEKQIKRKWTEDs K523
PARN (mouse) KQEGkQVkRKWTEDS K516-ac
PARN (rat) KQESKQVKRKWTEDS K516
S530-p
KRKWTEDsWkEADSK
0 1
PARN (human) KRKWTEDsWkEADSK S530-p
PARN (mouse) kRKWTEDSWKEVDRK S523
PARN (rat) KRKWTEDSWKEVDRK S523
K532-ub
KWTEDsWkEADSKRL
0 1
PARN (human) KWTEDsWkEADSKRL K532-ub
PARN (mouse) KWTEDSWKEVDRKRP K525
PARN (rat) KWTEDSWKEVDRKRP K525
Y552-p
PYTLQNHyYRNNsFT
0 1
PARN (human) PYTLQNHyYRNNsFT Y552-p
PARN (mouse) RPHMQGPCYHSNSFT C538
PARN (rat) RPHVPGPCYHTNSFT C538
S557-p
NHyYRNNsFTAPsTV
Upstream
Downstream
1 82
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • MAPKAPK2 (human)
Putative in vivo kinases:
  • MAPKAPK2 (human)
Treatment
  • angiotensin_2
  • ischemia
  • nocodazole
  • SII_angiotensin_2
PARN (human) NHyYRNNsFTAPsTV S557-p
PARN (mouse) GPCYHSNSFTAAGVL S543
PARN (rat) GPCYHTNSFTAAGIV S543
S562-p
NNsFTAPsTVGkRNL
0 2
PARN (human) NNsFTAPsTVGkRNL S562-p
PARN (mouse) SNSFTAAGVLGKRtL G548
PARN (rat) TNSFTAAGIVGKRTL G548
K566-ac
TAPsTVGkRNLsPsQ
0 23
PARN (human) TAPsTVGkRNLsPsQ K566-ac
PARN (mouse) TAAGVLGKRtLsPDP K552
PARN (rat) TAAGIVGKRTLsPDP K552
K566-ub
TAPsTVGkRNLsPsQ
0 2
PARN (human) TAPsTVGkRNLsPsQ K566-ub
PARN (mouse) under review -
PARN (rat) TAAGIVGKRTLsPDP K552
N568
PsTVGkRNLsPsQEE
0 1
PARN (human) PsTVGkRNLsPsQEE N568
PARN (mouse) AGVLGKRtLsPDPRE T554-p
PARN (rat) AGIVGKRTLsPDPRE T554
S570-p
TVGkRNLsPsQEEAG
0 22
PARN (human) TVGkRNLsPsQEEAG S570-p
PARN (mouse) VLGKRtLsPDPREAA S556-p
PARN (rat) IVGKRTLsPDPREAG S556-p
S572-p
GkRNLsPsQEEAGLE
0 3
PARN (human) GkRNLsPsQEEAGLE S572-p
PARN (mouse) GKRtLsPDPREAALE D558
PARN (rat) GKRTLsPDPREAGVV D558
S583-p
AGLEDGVsGEIsDtE
0 13
PARN (human) AGLEDGVsGEIsDtE S583-p
PARN (mouse) AALEDREsEEVsDsE S569-p
PARN (rat) AGVVDREsEGIsDPE S569-p
S587-p
DGVsGEIsDtELEQT
0 19
PARN (human) DGVsGEIsDtELEQT S587-p
PARN (mouse) DREsEEVsDsELEQT S573-p
PARN (rat) DREsEGIsDPELEQT S573-p
T589-p
VsGEIsDtELEQTDS
0 6
PARN (human) VsGEIsDtELEQTDS T589-p
PARN (mouse) EsEEVsDsELEQTDS S575-p
PARN (rat) EsEGIsDPELEQTDY P575
S619-p
KRMKKELsPAGsIsK
Upstream
0 45
Treatment
  • nocodazole
PARN (human) KRMKKELsPAGsIsK S619-p
PARN (mouse) KRMKKELSLAGSVSD S605
PARN (rat) KRMKKEFSLAGSASD S605
S623-p
KELsPAGsIsKNsPA
0 14
PARN (human) KELsPAGsIsKNsPA S623-p
PARN (mouse) KELSLAGSVSDSPAV S609
PARN (rat) KEFSLAGSASDSPAV S609
S625-p
LsPAGsIsKNsPAtL
0 1
PARN (human) LsPAGsIsKNsPAtL S625-p
PARN (mouse) LSLAGSVSDSPAVLF S611
PARN (rat) FSLAGSASDSPAVLF S611
S628-p
AGsIsKNsPAtLFEV
Upstream
0 10
Treatment
  • nocodazole
PARN (human) AGsIsKNsPAtLFEV S628-p
PARN (mouse) LAGSVSDSPAVLFEV S613
PARN (rat) LAGSASDSPAVLFEV S613
T631-p
IsKNsPAtLFEVPDt
Upstream
0 4
Treatment
  • nocodazole
PARN (human) IsKNsPAtLFEVPDt T631-p
PARN (mouse) SVSDSPAVLFEVPDT V616
PARN (rat) SASDSPAVLFEVPDT V616
T638-p
tLFEVPDtW______
0 2
PARN (human) tLFEVPDtW______ T638-p
PARN (mouse) VLFEVPDTW______ T623
PARN (rat) VLFEVPDTW______ T623